INSERM TRANSFERT SA
- Country
- France
- Type
- Beneficiary
- Website
- www.inserm-transfert.fr
- Grants received
- 102
Funding record
- 102 grants on record
- €34,306,780.87 awarded in total
- 2007–2026 years covered
This total adds up only the grants our sources publish. It is not the total funding this organisation has received.
Programmes
26 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations funded alongside this one on two or more projects. Sharing a single project does not count. Some projects have as many as 195 participants, and appearing on the same list once is not a working relationship.
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
- Katholieke Universiteit Leuven
- MEDIZINISCHE UNIVERSITAET WIEN
- KAROLINSKA INSTITUTET
- ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK
- ACADEMISCH ZIEKENHUIS LEIDEN
Calls from this organisation
No published calls from this organisation.
Grants received
- Microbiota–Immune–Cognition Relationships from Neonatal Environments to Social Trajectories
- Building a European strategic Research and Innovation Area in Direct Synergy with EU and International Initiatives for Pandemic Preparedness PLUS
- A European Proactive Adaptive Clinical Trials Network within EU-Response
- IMPROVing lifElong health and development for children and adults born very PRETERM – observational studies to enhance randomised trials for comparative effectiveness research
- Dissecting Brain Pollutant Exposure and its Contribution to Neurodegeneration and Alzheimer’s disease: From Signatures to Prevention Strategies to Protect and Maintain a Healthy Brain
- Assessing and improving access to health and social care SErvices for children RENdered vulnerable by Abuse
- Offering combined HPV vaccination and HPV test-based cervical screening to vulnerable populations. A hybrid efficacy and implementation study.
- Innovative designs, extrapolation, simulation methods and evidence-tools for rare diseases addressing regulatory needs
- Sustainable COVID-19 Vaccination for Long-term Vaccine Immunity and Effectiveness
- Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe)
- Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease (IBD) Immunotherapy (MITI2)
- Fighting childhood obesity to stay healthy all over the life
- Improving treatment efficacy in hypertension by biomarker-guided personalised decision support
- CArdiovascularREsolution of INflammation to promote HEALTH
- Early Interception of Inflammatory-mediated Type 2 Diabetes
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
We collected this from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.